nodes	percent_of_prediction	percent_of_DWPC	metapath
Aciclovir—SLC10A2—bile duct—liver cancer	0.211	0.552	CbGeAlD
Aciclovir—SLC10A2—bile—liver cancer	0.162	0.425	CbGeAlD
Aciclovir—SLC10A2—Recycling of bile acids and salts—NR1H4—liver cancer	0.023	0.117	CbGpPWpGaD
Aciclovir—SLC10A2—Bile acid and bile salt metabolism—NR1H4—liver cancer	0.012	0.0611	CbGpPWpGaD
Aciclovir—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00739	0.0376	CbGpPWpGaD
Aciclovir—SLC47A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00705	0.0359	CbGpPWpGaD
Aciclovir—SLC10A2—Recycling of bile acids and salts—ALB—liver cancer	0.00611	0.0311	CbGpPWpGaD
Aciclovir—SLC10A2—Orphan transporters—ANXA2—liver cancer	0.00543	0.0277	CbGpPWpGaD
Aciclovir—SLC10A2—Orphan transporters—NR1H4—liver cancer	0.00514	0.0262	CbGpPWpGaD
Aciclovir—SLC47A1—liver—liver cancer	0.0048	0.0126	CbGeAlD
Aciclovir—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00476	0.0242	CbGpPWpGaD
Aciclovir—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00454	0.0231	CbGpPWpGaD
Aciclovir—SLC22A1—liver—liver cancer	0.00401	0.0105	CbGeAlD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00336	0.0171	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00333	0.017	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00333	0.017	CbGpPWpGaD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.0032	0.0163	CbGpPWpGaD
Aciclovir—SLC10A2—Bile acid and bile salt metabolism—ALB—liver cancer	0.00319	0.0163	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00283	0.0144	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00283	0.0144	CbGpPWpGaD
Aciclovir—SLC10A2—Orphan transporters—CYCS—liver cancer	0.00262	0.0133	CbGpPWpGaD
Aciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00224	0.0114	CbGpPWpGaD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00216	0.011	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00215	0.0109	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00215	0.0109	CbGpPWpGaD
Aciclovir—Delirium—Epirubicin—liver cancer	0.00214	0.00508	CcSEcCtD
Aciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00214	0.0109	CbGpPWpGaD
Aciclovir—Dysgeusia—Sorafenib—liver cancer	0.00213	0.00506	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00212	0.0108	CbGpPWpGaD
Aciclovir—Stinging—Doxorubicin—liver cancer	0.0021	0.00499	CcSEcCtD
Aciclovir—Muscle spasms—Sorafenib—liver cancer	0.00209	0.00497	CcSEcCtD
Aciclovir—Rigors—Doxorubicin—liver cancer	0.00209	0.00496	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00206	0.0105	CbGpPWpGaD
Aciclovir—Hyperbilirubinaemia—Epirubicin—liver cancer	0.00203	0.00481	CcSEcCtD
Aciclovir—Anaemia—Sorafenib—liver cancer	0.00201	0.00478	CcSEcCtD
Aciclovir—Herpes simplex—Epirubicin—liver cancer	0.002	0.00474	CcSEcCtD
Aciclovir—Angioedema—Sorafenib—liver cancer	0.00199	0.00473	CcSEcCtD
Aciclovir—Delirium—Doxorubicin—liver cancer	0.00198	0.0047	CcSEcCtD
Aciclovir—Leukopenia—Sorafenib—liver cancer	0.00195	0.00463	CcSEcCtD
Aciclovir—Dysarthria—Epirubicin—liver cancer	0.00195	0.00462	CcSEcCtD
Aciclovir—Creatinine increased—Epirubicin—liver cancer	0.00194	0.00459	CcSEcCtD
Aciclovir—Inflammation—Epirubicin—liver cancer	0.0019	0.00451	CcSEcCtD
Aciclovir—Hypertension—Sorafenib—liver cancer	0.00188	0.00447	CcSEcCtD
Aciclovir—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00187	0.00445	CcSEcCtD
Aciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00187	0.00953	CbGpPWpGaD
Aciclovir—Myalgia—Sorafenib—liver cancer	0.00186	0.0044	CcSEcCtD
Aciclovir—Arthralgia—Sorafenib—liver cancer	0.00186	0.0044	CcSEcCtD
Aciclovir—Herpes simplex—Doxorubicin—liver cancer	0.00185	0.00439	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00184	0.00437	CcSEcCtD
Aciclovir—Phosphatase alkaline increased—Epirubicin—liver cancer	0.00184	0.00437	CcSEcCtD
Aciclovir—SLC10A2—Orphan transporters—PPARA—liver cancer	0.00184	0.00937	CbGpPWpGaD
Aciclovir—Dermatitis contact—Epirubicin—liver cancer	0.00182	0.00432	CcSEcCtD
Aciclovir—Dysarthria—Doxorubicin—liver cancer	0.0018	0.00428	CcSEcCtD
Aciclovir—Creatinine increased—Doxorubicin—liver cancer	0.00179	0.00425	CcSEcCtD
Aciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00179	0.00909	CbGpPWpGaD
Aciclovir—Anaphylactic shock—Sorafenib—liver cancer	0.00178	0.00422	CcSEcCtD
Aciclovir—Skin exfoliation—Epirubicin—liver cancer	0.00176	0.00417	CcSEcCtD
Aciclovir—Inflammation—Doxorubicin—liver cancer	0.00176	0.00417	CcSEcCtD
Aciclovir—Nervous system disorder—Sorafenib—liver cancer	0.00174	0.00414	CcSEcCtD
Aciclovir—Thrombocytopenia—Sorafenib—liver cancer	0.00174	0.00413	CcSEcCtD
Aciclovir—Blood urea increased—Epirubicin—liver cancer	0.00174	0.00413	CcSEcCtD
Aciclovir—Aplastic anaemia—Epirubicin—liver cancer	0.00173	0.00411	CcSEcCtD
Aciclovir—Skin disorder—Sorafenib—liver cancer	0.00173	0.0041	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00171	0.00869	CbGpPWpGaD
Aciclovir—Phosphatase alkaline increased—Doxorubicin—liver cancer	0.0017	0.00405	CcSEcCtD
Aciclovir—Anorexia—Sorafenib—liver cancer	0.0017	0.00402	CcSEcCtD
Aciclovir—Dermatitis contact—Doxorubicin—liver cancer	0.00168	0.004	CcSEcCtD
Aciclovir—Coma—Epirubicin—liver cancer	0.00168	0.004	CcSEcCtD
Aciclovir—Pulmonary oedema—Epirubicin—liver cancer	0.00164	0.00389	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00163	0.00829	CbGpPWpGaD
Aciclovir—Skin exfoliation—Doxorubicin—liver cancer	0.00163	0.00386	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00162	0.00385	CcSEcCtD
Aciclovir—Blood urea increased—Doxorubicin—liver cancer	0.00161	0.00382	CcSEcCtD
Aciclovir—Aplastic anaemia—Doxorubicin—liver cancer	0.0016	0.0038	CcSEcCtD
Aciclovir—Dyspnoea—Sorafenib—liver cancer	0.00159	0.00376	CcSEcCtD
Aciclovir—Lymphadenopathy—Epirubicin—liver cancer	0.00157	0.00372	CcSEcCtD
Aciclovir—Dyspepsia—Sorafenib—liver cancer	0.00157	0.00372	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00156	0.00795	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00156	0.00795	CbGpPWpGaD
Aciclovir—Coma—Doxorubicin—liver cancer	0.00156	0.0037	CcSEcCtD
Aciclovir—Phlebitis—Epirubicin—liver cancer	0.00155	0.00368	CcSEcCtD
Aciclovir—Decreased appetite—Sorafenib—liver cancer	0.00155	0.00367	CcSEcCtD
Aciclovir—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00154	0.00365	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Sorafenib—liver cancer	0.00154	0.00364	CcSEcCtD
Aciclovir—Fatigue—Sorafenib—liver cancer	0.00153	0.00364	CcSEcCtD
Aciclovir—Photosensitivity—Epirubicin—liver cancer	0.00152	0.00361	CcSEcCtD
Aciclovir—Constipation—Sorafenib—liver cancer	0.00152	0.00361	CcSEcCtD
Aciclovir—Pain—Sorafenib—liver cancer	0.00152	0.00361	CcSEcCtD
Aciclovir—Pulmonary oedema—Doxorubicin—liver cancer	0.00152	0.0036	CcSEcCtD
Aciclovir—Eczema—Epirubicin—liver cancer	0.00149	0.00353	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00148	0.00751	CbGpPWpGaD
Aciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00145	0.00741	CbGpPWpGaD
Aciclovir—Gastrointestinal pain—Sorafenib—liver cancer	0.00145	0.00345	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00145	0.00739	CbGpPWpGaD
Aciclovir—Lymphadenopathy—Doxorubicin—liver cancer	0.00145	0.00344	CcSEcCtD
Aciclovir—Renal failure acute—Epirubicin—liver cancer	0.00145	0.00344	CcSEcCtD
Aciclovir—Phlebitis—Doxorubicin—liver cancer	0.00144	0.00341	CcSEcCtD
Aciclovir—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00142	0.00338	CcSEcCtD
Aciclovir—Urticaria—Sorafenib—liver cancer	0.00141	0.00335	CcSEcCtD
Aciclovir—Photosensitivity—Doxorubicin—liver cancer	0.00141	0.00334	CcSEcCtD
Aciclovir—Body temperature increased—Sorafenib—liver cancer	0.00141	0.00334	CcSEcCtD
Aciclovir—Abdominal pain—Sorafenib—liver cancer	0.00141	0.00334	CcSEcCtD
Aciclovir—Renal impairment—Epirubicin—liver cancer	0.00141	0.00334	CcSEcCtD
Aciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00139	0.00707	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00138	0.00705	CbGpPWpGaD
Aciclovir—Eczema—Doxorubicin—liver cancer	0.00138	0.00327	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00137	0.00697	CbGpPWpGaD
Aciclovir—Lethargy—Epirubicin—liver cancer	0.00136	0.00324	CcSEcCtD
Aciclovir—Renal failure acute—Doxorubicin—liver cancer	0.00134	0.00318	CcSEcCtD
Aciclovir—Pain in extremity—Epirubicin—liver cancer	0.00134	0.00317	CcSEcCtD
Aciclovir—Osteoarthritis—Epirubicin—liver cancer	0.00134	0.00317	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00133	0.00676	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00133	0.00676	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00132	0.00672	CbGpPWpGaD
Aciclovir—Hypersensitivity—Sorafenib—liver cancer	0.00131	0.00311	CcSEcCtD
Aciclovir—Renal impairment—Doxorubicin—liver cancer	0.0013	0.00309	CcSEcCtD
Aciclovir—Face oedema—Epirubicin—liver cancer	0.00129	0.00306	CcSEcCtD
Aciclovir—Asthenia—Sorafenib—liver cancer	0.00128	0.00303	CcSEcCtD
Aciclovir—Lethargy—Doxorubicin—liver cancer	0.00126	0.003	CcSEcCtD
Aciclovir—Pruritus—Sorafenib—liver cancer	0.00126	0.00299	CcSEcCtD
Aciclovir—Ataxia—Epirubicin—liver cancer	0.00126	0.00298	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00125	0.00639	CbGpPWpGaD
Aciclovir—Blood creatinine increased—Epirubicin—liver cancer	0.00125	0.00297	CcSEcCtD
Aciclovir—Dehydration—Epirubicin—liver cancer	0.00124	0.00295	CcSEcCtD
Aciclovir—Pain in extremity—Doxorubicin—liver cancer	0.00124	0.00294	CcSEcCtD
Aciclovir—Osteoarthritis—Doxorubicin—liver cancer	0.00124	0.00294	CcSEcCtD
Aciclovir—Liver function test abnormal—Epirubicin—liver cancer	0.00123	0.00293	CcSEcCtD
Aciclovir—Hypokalaemia—Epirubicin—liver cancer	0.00122	0.00289	CcSEcCtD
Aciclovir—Diarrhoea—Sorafenib—liver cancer	0.00122	0.00289	CcSEcCtD
Aciclovir—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.0012	0.00286	CcSEcCtD
Aciclovir—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.0012	0.00286	CcSEcCtD
Aciclovir—Nasopharyngitis—Epirubicin—liver cancer	0.0012	0.00284	CcSEcCtD
Aciclovir—Face oedema—Doxorubicin—liver cancer	0.00119	0.00284	CcSEcCtD
Aciclovir—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00118	0.0028	CcSEcCtD
Aciclovir—Dizziness—Sorafenib—liver cancer	0.00118	0.00279	CcSEcCtD
Aciclovir—Ataxia—Doxorubicin—liver cancer	0.00116	0.00276	CcSEcCtD
Aciclovir—Blood creatinine increased—Doxorubicin—liver cancer	0.00116	0.00275	CcSEcCtD
Aciclovir—Dehydration—Doxorubicin—liver cancer	0.00115	0.00273	CcSEcCtD
Aciclovir—Liver function test abnormal—Doxorubicin—liver cancer	0.00114	0.00271	CcSEcCtD
Aciclovir—Vomiting—Sorafenib—liver cancer	0.00113	0.00268	CcSEcCtD
Aciclovir—Hypokalaemia—Doxorubicin—liver cancer	0.00113	0.00267	CcSEcCtD
Aciclovir—Rash—Sorafenib—liver cancer	0.00112	0.00266	CcSEcCtD
Aciclovir—Dermatitis—Sorafenib—liver cancer	0.00112	0.00266	CcSEcCtD
Aciclovir—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00111	0.00264	CcSEcCtD
Aciclovir—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00111	0.00264	CcSEcCtD
Aciclovir—Headache—Sorafenib—liver cancer	0.00111	0.00264	CcSEcCtD
Aciclovir—Nasopharyngitis—Doxorubicin—liver cancer	0.00111	0.00263	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.0011	0.0056	CbGpPWpGaD
Aciclovir—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00109	0.00259	CcSEcCtD
Aciclovir—Neutropenia—Epirubicin—liver cancer	0.00108	0.00257	CcSEcCtD
Aciclovir—Upper respiratory tract infection—Epirubicin—liver cancer	0.00107	0.00255	CcSEcCtD
Aciclovir—Nausea—Sorafenib—liver cancer	0.00106	0.00251	CcSEcCtD
Aciclovir—Photosensitivity reaction—Epirubicin—liver cancer	0.00105	0.0025	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00105	0.00534	CbGpPWpGaD
Aciclovir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00102	0.00242	CcSEcCtD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00102	0.00519	CbGpPWpGaD
Aciclovir—Renal failure—Epirubicin—liver cancer	0.00101	0.0024	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00101	0.00515	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00101	0.00515	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00101	0.00514	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—UGDH—liver cancer	0.00101	0.00512	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00101	0.00512	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00101	0.00512	CbGpPWpGaD
Aciclovir—Jaundice—Epirubicin—liver cancer	0.001	0.00238	CcSEcCtD
Aciclovir—Conjunctivitis—Epirubicin—liver cancer	0.001	0.00238	CcSEcCtD
Aciclovir—Neutropenia—Doxorubicin—liver cancer	0.001	0.00237	CcSEcCtD
Aciclovir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000994	0.00236	CcSEcCtD
Aciclovir—Haematuria—Epirubicin—liver cancer	0.000982	0.00233	CcSEcCtD
Aciclovir—Photosensitivity reaction—Doxorubicin—liver cancer	0.000976	0.00232	CcSEcCtD
Aciclovir—Hepatobiliary disease—Epirubicin—liver cancer	0.000975	0.00231	CcSEcCtD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000972	0.00495	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000951	0.00484	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—EPT1—liver cancer	0.000946	0.00482	CbGpPWpGaD
Aciclovir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000945	0.00224	CcSEcCtD
Aciclovir—Renal failure—Doxorubicin—liver cancer	0.000937	0.00222	CcSEcCtD
Aciclovir—Jaundice—Doxorubicin—liver cancer	0.000929	0.00221	CcSEcCtD
Aciclovir—Conjunctivitis—Doxorubicin—liver cancer	0.000927	0.0022	CcSEcCtD
Aciclovir—Hepatitis—Epirubicin—liver cancer	0.000925	0.0022	CcSEcCtD
Aciclovir—Urinary tract disorder—Epirubicin—liver cancer	0.000914	0.00217	CcSEcCtD
Aciclovir—Oedema peripheral—Epirubicin—liver cancer	0.000911	0.00216	CcSEcCtD
Aciclovir—Haematuria—Doxorubicin—liver cancer	0.000909	0.00216	CcSEcCtD
Aciclovir—Urethral disorder—Epirubicin—liver cancer	0.000907	0.00215	CcSEcCtD
Aciclovir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000902	0.00214	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—TAT—liver cancer	0.000896	0.00457	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000882	0.00449	CbGpPWpGaD
Aciclovir—Erythema multiforme—Epirubicin—liver cancer	0.000875	0.00208	CcSEcCtD
Aciclovir—Eye disorder—Epirubicin—liver cancer	0.000864	0.00205	CcSEcCtD
Aciclovir—Hepatitis—Doxorubicin—liver cancer	0.000856	0.00203	CcSEcCtD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000851	0.00433	CbGpPWpGaD
Aciclovir—Urinary tract disorder—Doxorubicin—liver cancer	0.000845	0.00201	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000844	0.0043	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000844	0.0043	CbGpPWpGaD
Aciclovir—Oedema peripheral—Doxorubicin—liver cancer	0.000843	0.002	CcSEcCtD
Aciclovir—Urethral disorder—Doxorubicin—liver cancer	0.000839	0.00199	CcSEcCtD
Aciclovir—Immune system disorder—Epirubicin—liver cancer	0.000836	0.00198	CcSEcCtD
Aciclovir—Mediastinal disorder—Epirubicin—liver cancer	0.000834	0.00198	CcSEcCtD
Aciclovir—Chills—Epirubicin—liver cancer	0.00083	0.00197	CcSEcCtD
Aciclovir—Alopecia—Epirubicin—liver cancer	0.000817	0.00194	CcSEcCtD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000812	0.00413	CbGpPWpGaD
Aciclovir—Erythema multiforme—Doxorubicin—liver cancer	0.000809	0.00192	CcSEcCtD
Aciclovir—Erythema—Epirubicin—liver cancer	0.000805	0.00191	CcSEcCtD
Aciclovir—Eye disorder—Doxorubicin—liver cancer	0.0008	0.0019	CcSEcCtD
Aciclovir—Flatulence—Epirubicin—liver cancer	0.000793	0.00188	CcSEcCtD
Aciclovir—Dysgeusia—Epirubicin—liver cancer	0.000789	0.00187	CcSEcCtD
Aciclovir—Muscle spasms—Epirubicin—liver cancer	0.000774	0.00184	CcSEcCtD
Aciclovir—Immune system disorder—Doxorubicin—liver cancer	0.000773	0.00184	CcSEcCtD
Aciclovir—SLC47A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000772	0.00393	CbGpPWpGaD
Aciclovir—Mediastinal disorder—Doxorubicin—liver cancer	0.000771	0.00183	CcSEcCtD
Aciclovir—Chills—Doxorubicin—liver cancer	0.000768	0.00182	CcSEcCtD
Aciclovir—Alopecia—Doxorubicin—liver cancer	0.000756	0.0018	CcSEcCtD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000752	0.00383	CbGpPWpGaD
Aciclovir—Ill-defined disorder—Epirubicin—liver cancer	0.000747	0.00177	CcSEcCtD
Aciclovir—Erythema—Doxorubicin—liver cancer	0.000745	0.00177	CcSEcCtD
Aciclovir—Anaemia—Epirubicin—liver cancer	0.000744	0.00177	CcSEcCtD
Aciclovir—Agitation—Epirubicin—liver cancer	0.00074	0.00176	CcSEcCtD
Aciclovir—Flatulence—Doxorubicin—liver cancer	0.000734	0.00174	CcSEcCtD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—GLUL—liver cancer	0.000731	0.00372	CbGpPWpGaD
Aciclovir—Dysgeusia—Doxorubicin—liver cancer	0.00073	0.00173	CcSEcCtD
Aciclovir—Malaise—Epirubicin—liver cancer	0.000726	0.00172	CcSEcCtD
Aciclovir—Vertigo—Epirubicin—liver cancer	0.000723	0.00172	CcSEcCtD
Aciclovir—Leukopenia—Epirubicin—liver cancer	0.000721	0.00171	CcSEcCtD
Aciclovir—Muscle spasms—Doxorubicin—liver cancer	0.000716	0.0017	CcSEcCtD
Aciclovir—Palpitations—Epirubicin—liver cancer	0.000712	0.00169	CcSEcCtD
Aciclovir—Convulsion—Epirubicin—liver cancer	0.000698	0.00166	CcSEcCtD
Aciclovir—Hypertension—Epirubicin—liver cancer	0.000695	0.00165	CcSEcCtD
Aciclovir—Ill-defined disorder—Doxorubicin—liver cancer	0.000691	0.00164	CcSEcCtD
Aciclovir—Anaemia—Doxorubicin—liver cancer	0.000689	0.00163	CcSEcCtD
Aciclovir—Chest pain—Epirubicin—liver cancer	0.000686	0.00163	CcSEcCtD
Aciclovir—Arthralgia—Epirubicin—liver cancer	0.000686	0.00163	CcSEcCtD
Aciclovir—Myalgia—Epirubicin—liver cancer	0.000686	0.00163	CcSEcCtD
Aciclovir—Agitation—Doxorubicin—liver cancer	0.000685	0.00163	CcSEcCtD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000681	0.00162	CcSEcCtD
Aciclovir—Discomfort—Epirubicin—liver cancer	0.000677	0.00161	CcSEcCtD
Aciclovir—Malaise—Doxorubicin—liver cancer	0.000672	0.00159	CcSEcCtD
Aciclovir—Vertigo—Doxorubicin—liver cancer	0.000669	0.00159	CcSEcCtD
Aciclovir—Leukopenia—Doxorubicin—liver cancer	0.000667	0.00158	CcSEcCtD
Aciclovir—Confusional state—Epirubicin—liver cancer	0.000663	0.00157	CcSEcCtD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.000661	0.00337	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00066	0.00336	CbGpPWpGaD
Aciclovir—Palpitations—Doxorubicin—liver cancer	0.000658	0.00156	CcSEcCtD
Aciclovir—Oedema—Epirubicin—liver cancer	0.000657	0.00156	CcSEcCtD
Aciclovir—Anaphylactic shock—Epirubicin—liver cancer	0.000657	0.00156	CcSEcCtD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000656	0.00334	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000656	0.00334	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000654	0.00333	CbGpPWpGaD
Aciclovir—Convulsion—Doxorubicin—liver cancer	0.000646	0.00153	CcSEcCtD
Aciclovir—Nervous system disorder—Epirubicin—liver cancer	0.000644	0.00153	CcSEcCtD
Aciclovir—Thrombocytopenia—Epirubicin—liver cancer	0.000643	0.00153	CcSEcCtD
Aciclovir—Hypertension—Doxorubicin—liver cancer	0.000643	0.00153	CcSEcCtD
Aciclovir—Tachycardia—Epirubicin—liver cancer	0.000641	0.00152	CcSEcCtD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000639	0.00326	CbGpPWpGaD
Aciclovir—Skin disorder—Epirubicin—liver cancer	0.000638	0.00152	CcSEcCtD
Aciclovir—Hyperhidrosis—Epirubicin—liver cancer	0.000635	0.00151	CcSEcCtD
Aciclovir—Arthralgia—Doxorubicin—liver cancer	0.000634	0.00151	CcSEcCtD
Aciclovir—Myalgia—Doxorubicin—liver cancer	0.000634	0.00151	CcSEcCtD
Aciclovir—Chest pain—Doxorubicin—liver cancer	0.000634	0.00151	CcSEcCtD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000631	0.00321	CbGpPWpGaD
Aciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00063	0.0015	CcSEcCtD
Aciclovir—Discomfort—Doxorubicin—liver cancer	0.000627	0.00149	CcSEcCtD
Aciclovir—Anorexia—Epirubicin—liver cancer	0.000626	0.00149	CcSEcCtD
Aciclovir—Hypotension—Epirubicin—liver cancer	0.000614	0.00146	CcSEcCtD
Aciclovir—Confusional state—Doxorubicin—liver cancer	0.000613	0.00146	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CPT1B—liver cancer	0.000609	0.0031	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GLUL—liver cancer	0.000609	0.0031	CbGpPWpGaD
Aciclovir—Anaphylactic shock—Doxorubicin—liver cancer	0.000608	0.00144	CcSEcCtD
Aciclovir—Oedema—Doxorubicin—liver cancer	0.000608	0.00144	CcSEcCtD
Aciclovir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000599	0.00142	CcSEcCtD
Aciclovir—Nervous system disorder—Doxorubicin—liver cancer	0.000596	0.00142	CcSEcCtD
Aciclovir—Thrombocytopenia—Doxorubicin—liver cancer	0.000595	0.00141	CcSEcCtD
Aciclovir—Insomnia—Epirubicin—liver cancer	0.000594	0.00141	CcSEcCtD
Aciclovir—Tachycardia—Doxorubicin—liver cancer	0.000593	0.00141	CcSEcCtD
Aciclovir—Skin disorder—Doxorubicin—liver cancer	0.000591	0.0014	CcSEcCtD
Aciclovir—Paraesthesia—Epirubicin—liver cancer	0.00059	0.0014	CcSEcCtD
Aciclovir—Hyperhidrosis—Doxorubicin—liver cancer	0.000588	0.0014	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—NR1H4—liver cancer	0.000588	0.00299	CbGpPWpGaD
Aciclovir—Dyspnoea—Epirubicin—liver cancer	0.000586	0.00139	CcSEcCtD
Aciclovir—Somnolence—Epirubicin—liver cancer	0.000584	0.00139	CcSEcCtD
Aciclovir—Anorexia—Doxorubicin—liver cancer	0.00058	0.00138	CcSEcCtD
Aciclovir—Dyspepsia—Epirubicin—liver cancer	0.000579	0.00137	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GSTA3—liver cancer	0.000578	0.00294	CbGpPWpGaD
Aciclovir—Decreased appetite—Epirubicin—liver cancer	0.000571	0.00136	CcSEcCtD
Aciclovir—Hypotension—Doxorubicin—liver cancer	0.000568	0.00135	CcSEcCtD
Aciclovir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000567	0.00135	CcSEcCtD
Aciclovir—Fatigue—Epirubicin—liver cancer	0.000567	0.00134	CcSEcCtD
Aciclovir—Constipation—Epirubicin—liver cancer	0.000562	0.00133	CcSEcCtD
Aciclovir—Pain—Epirubicin—liver cancer	0.000562	0.00133	CcSEcCtD
Aciclovir—SLC22A1—Neuronal System—GLUL—liver cancer	0.00056	0.00285	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000556	0.00283	CbGpPWpGaD
Aciclovir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000554	0.00132	CcSEcCtD
Aciclovir—Insomnia—Doxorubicin—liver cancer	0.00055	0.00131	CcSEcCtD
Aciclovir—Paraesthesia—Doxorubicin—liver cancer	0.000546	0.0013	CcSEcCtD
Aciclovir—Dyspnoea—Doxorubicin—liver cancer	0.000542	0.00129	CcSEcCtD
Aciclovir—Feeling abnormal—Epirubicin—liver cancer	0.000542	0.00129	CcSEcCtD
Aciclovir—Somnolence—Doxorubicin—liver cancer	0.000541	0.00128	CcSEcCtD
Aciclovir—Gastrointestinal pain—Epirubicin—liver cancer	0.000537	0.00128	CcSEcCtD
Aciclovir—Dyspepsia—Doxorubicin—liver cancer	0.000535	0.00127	CcSEcCtD
Aciclovir—Decreased appetite—Doxorubicin—liver cancer	0.000529	0.00125	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GSTA4—liver cancer	0.000528	0.00269	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000528	0.00269	CbGpPWpGaD
Aciclovir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000525	0.00125	CcSEcCtD
Aciclovir—Fatigue—Doxorubicin—liver cancer	0.000524	0.00124	CcSEcCtD
Aciclovir—Urticaria—Epirubicin—liver cancer	0.000522	0.00124	CcSEcCtD
Aciclovir—Pain—Doxorubicin—liver cancer	0.00052	0.00123	CcSEcCtD
Aciclovir—Constipation—Doxorubicin—liver cancer	0.00052	0.00123	CcSEcCtD
Aciclovir—Body temperature increased—Epirubicin—liver cancer	0.00052	0.00123	CcSEcCtD
Aciclovir—Abdominal pain—Epirubicin—liver cancer	0.00052	0.00123	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000518	0.00264	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000516	0.00263	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTA2—liver cancer	0.000515	0.00262	CbGpPWpGaD
Aciclovir—Feeling abnormal—Doxorubicin—liver cancer	0.000501	0.00119	CcSEcCtD
Aciclovir—SLC47A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000498	0.00253	CbGpPWpGaD
Aciclovir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000497	0.00118	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—GSTA1—liver cancer	0.000497	0.00253	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000494	0.00252	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—NAT2—liver cancer	0.000491	0.0025	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000485	0.00247	CbGpPWpGaD
Aciclovir—Hypersensitivity—Epirubicin—liver cancer	0.000484	0.00115	CcSEcCtD
Aciclovir—Urticaria—Doxorubicin—liver cancer	0.000483	0.00115	CcSEcCtD
Aciclovir—Body temperature increased—Doxorubicin—liver cancer	0.000481	0.00114	CcSEcCtD
Aciclovir—Abdominal pain—Doxorubicin—liver cancer	0.000481	0.00114	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000474	0.00241	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000474	0.00241	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000472	0.00241	CbGpPWpGaD
Aciclovir—Asthenia—Epirubicin—liver cancer	0.000472	0.00112	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—ALDOB—liver cancer	0.000471	0.0024	CbGpPWpGaD
Aciclovir—Pruritus—Epirubicin—liver cancer	0.000465	0.0011	CcSEcCtD
Aciclovir—Diarrhoea—Epirubicin—liver cancer	0.00045	0.00107	CcSEcCtD
Aciclovir—SLC10A2—Metabolism—CRABP1—liver cancer	0.000449	0.00229	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000449	0.00229	CbGpPWpGaD
Aciclovir—Hypersensitivity—Doxorubicin—liver cancer	0.000448	0.00106	CcSEcCtD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000448	0.00228	CbGpPWpGaD
Aciclovir—Asthenia—Doxorubicin—liver cancer	0.000436	0.00104	CcSEcCtD
Aciclovir—Dizziness—Epirubicin—liver cancer	0.000435	0.00103	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000432	0.0022	CbGpPWpGaD
Aciclovir—Pruritus—Doxorubicin—liver cancer	0.00043	0.00102	CcSEcCtD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000421	0.00215	CbGpPWpGaD
Aciclovir—Vomiting—Epirubicin—liver cancer	0.000418	0.000992	CcSEcCtD
Aciclovir—Diarrhoea—Doxorubicin—liver cancer	0.000416	0.000988	CcSEcCtD
Aciclovir—Rash—Epirubicin—liver cancer	0.000414	0.000984	CcSEcCtD
Aciclovir—Dermatitis—Epirubicin—liver cancer	0.000414	0.000983	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000412	0.0021	CbGpPWpGaD
Aciclovir—Headache—Epirubicin—liver cancer	0.000412	0.000977	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000404	0.00206	CbGpPWpGaD
Aciclovir—Dizziness—Doxorubicin—liver cancer	0.000402	0.000954	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000395	0.00201	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000395	0.00201	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HPGDS—liver cancer	0.000393	0.002	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000393	0.002	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.00039	0.00199	CbGpPWpGaD
Aciclovir—Nausea—Epirubicin—liver cancer	0.00039	0.000927	CcSEcCtD
Aciclovir—Vomiting—Doxorubicin—liver cancer	0.000387	0.000918	CcSEcCtD
Aciclovir—Rash—Doxorubicin—liver cancer	0.000383	0.00091	CcSEcCtD
Aciclovir—Dermatitis—Doxorubicin—liver cancer	0.000383	0.000909	CcSEcCtD
Aciclovir—Headache—Doxorubicin—liver cancer	0.000381	0.000904	CcSEcCtD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000374	0.0019	CbGpPWpGaD
Aciclovir—Nausea—Doxorubicin—liver cancer	0.000361	0.000857	CcSEcCtD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000356	0.00181	CbGpPWpGaD
Aciclovir—SLC47A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000355	0.00181	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000351	0.00179	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PSMD10—liver cancer	0.00035	0.00178	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PSMA4—liver cancer	0.00035	0.00178	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GOT2—liver cancer	0.00034	0.00173	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.00034	0.00173	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000336	0.00171	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—ALB—liver cancer	0.000334	0.0017	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00032	0.00163	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP2E1—liver cancer	0.00032	0.00163	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.00031	0.00158	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000307	0.00156	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000307	0.00156	CbGpPWpGaD
Aciclovir—SLC10A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000302	0.00154	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYCS—liver cancer	0.000299	0.00153	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GGT1—liver cancer	0.000294	0.0015	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GOT1—liver cancer	0.000294	0.0015	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000291	0.00148	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTP1—liver cancer	0.000264	0.00134	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—HMOX1—liver cancer	0.00026	0.00133	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000253	0.00129	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—GSTM1—liver cancer	0.000243	0.00124	CbGpPWpGaD
Aciclovir—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	0.000235	0.00119	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—UGDH—liver cancer	0.000233	0.00119	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—CYP1A1—liver cancer	0.00023	0.00117	CbGpPWpGaD
Aciclovir—SLC47A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000229	0.00116	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	0.000228	0.00116	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—EPT1—liver cancer	0.000219	0.00112	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—MTHFR—liver cancer	0.000214	0.00109	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PPARA—liver cancer	0.00021	0.00107	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—TAT—liver cancer	0.000208	0.00106	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—BRAF—liver cancer	0.000203	0.00103	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000198	0.00101	CbGpPWpGaD
Aciclovir—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000196	0.000997	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000191	0.00097	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000189	0.000962	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CG—liver cancer	0.00018	0.000917	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PPARG—liver cancer	0.000174	0.000885	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—RAF1—liver cancer	0.00017	0.000864	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000166	0.000844	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	0.00016	0.000817	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CD—liver cancer	0.000158	0.000806	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—ALB—liver cancer	0.000156	0.000796	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—BRAF—liver cancer	0.000156	0.000793	CbGpPWpGaD
Aciclovir—SLC22A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000152	0.000775	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000148	0.000754	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CPT1B—liver cancer	0.000141	0.000719	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GLUL—liver cancer	0.000141	0.000719	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CB—liver cancer	0.000138	0.000703	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NR1H4—liver cancer	0.000136	0.000693	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000134	0.000682	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA3—liver cancer	0.000134	0.000681	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—RAF1—liver cancer	0.00013	0.000662	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000129	0.000656	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA4—liver cancer	0.000122	0.000623	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA2—liver cancer	0.000119	0.000607	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	0.000119	0.000607	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTA1—liver cancer	0.000115	0.000586	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—NAT2—liver cancer	0.000114	0.000579	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALDOB—liver cancer	0.000109	0.000555	CbGpPWpGaD
Aciclovir—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	0.000108	0.000549	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CRABP1—liver cancer	0.000104	0.00053	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000104	0.00053	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	9.95e-05	0.000507	CbGpPWpGaD
Aciclovir—SLC22A1—Transmission across Chemical Synapses—HRAS—liver cancer	9.34e-05	0.000476	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HPGDS—liver cancer	9.09e-05	0.000463	CbGpPWpGaD
Aciclovir—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	9e-05	0.000458	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—PIK3CA—liver cancer	8.41e-05	0.000428	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PSMA4—liver cancer	8.1e-05	0.000413	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PSMD10—liver cancer	8.1e-05	0.000413	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GOT2—liver cancer	7.88e-05	0.000401	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—ALB—liver cancer	7.73e-05	0.000394	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP2E1—liver cancer	7.41e-05	0.000377	CbGpPWpGaD
Aciclovir—SLC22A1—Neuronal System—HRAS—liver cancer	7.16e-05	0.000365	CbGpPWpGaD
Aciclovir—SLC22A1—Transmembrane transport of small molecules—RAF1—liver cancer	6.99e-05	0.000356	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYCS—liver cancer	6.94e-05	0.000353	CbGpPWpGaD
Aciclovir—SLC10A2—Metabolism—AKT1—liver cancer	6.87e-05	0.00035	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GOT1—liver cancer	6.81e-05	0.000347	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GGT1—liver cancer	6.81e-05	0.000347	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTP1—liver cancer	6.11e-05	0.000311	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—HMOX1—liver cancer	6.03e-05	0.000307	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—GSTM1—liver cancer	5.62e-05	0.000286	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—CYP1A1—liver cancer	5.33e-05	0.000271	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—MTHFR—liver cancer	4.96e-05	0.000253	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PPARA—liver cancer	4.87e-05	0.000248	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CG—liver cancer	4.17e-05	0.000212	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PPARG—liver cancer	4.03e-05	0.000205	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CD—liver cancer	3.67e-05	0.000187	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—ALB—liver cancer	3.62e-05	0.000184	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CB—liver cancer	3.2e-05	0.000163	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—PIK3CA—liver cancer	1.95e-05	9.92e-05	CbGpPWpGaD
Aciclovir—SLC22A1—Metabolism—AKT1—liver cancer	1.59e-05	8.11e-05	CbGpPWpGaD
